Photo: Freepik
The Strategy broadly defines where the state plans to invest most actively in coming years and in which directions it expects progress from scientific and federal medical centers.
One key development direction for Russian medicine, according to the document, is biomedical cellular products and personalized therapy. This includes creating CAR-T therapy for oncohematological patients.
This treatment type is actively developing in Russia: in 2026, the National Medical Research Center of Hematology plans to begin industrial production of its own CAR-T drug (capacity up to 600 units annually). Similar developments are underway at the Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, and the National Medical Research Radiological Center (Tsyb Medical Radiological Research Center in Obninsk). Currently, six domestic cellular therapy drugs are undergoing clinical trials in Russia. Marus Media covered this topic in its latest review.
Personalized therapy also includes cancer vaccines now being tested in major oncology medical centers.
State resources will also support bioprinting and tissue engineering development. Recent breakthrough Russian developments in this area include "artificial skin," 3D vertebral implants, and eardrum reconstruction.
Radiopharmaceuticals also made the list of medicine development priorities in Russia. They're used in Russian private and public clinics for diagnosing and treating specific cancer types. More on that in the Marus Media article.
The list includes molecular diagnostic methods already in active clinical practice for identifying gene mutations. Such tests are used for targeted cancer therapy and in predictive genetics for identifying hereditary risks.
According to the Strategy, a promising segment is a range of neurotechnologies for patient recovery and treatment. These include neuroprosthetics, for example, cochlear implants for restoring hearing, as well as deep brain stimulation technologies for Parkinson's disease and other neurodegenerative conditions.
Over the next five years, artificial intelligence technologies will be actively developed. So far, clinics and research centers in Russia have achieved greatest success in analyzing medical images to assist physicians with diagnosis. According to the latest data, 48 medical AI solutions are registered in Russia.
Source: Presidential Decree of the Russian Federation
All information on this website is provided for informational purposes only and does not constitute medical advice. All medical procedures require prior consultation with a licensed physician. Treatment outcomes may vary depending on individual characteristics. We do not guarantee any specific results. Always consult a medical professional before making any healthcare decisions.